RecruitingNot ApplicableNCT07655388

Wound Healing, Dressing Type, and Dressing Change Frequency in THA

Impact of Dressing Type and Dressing Change Frequency on Surgical Wound Healing Following Primary Total Hip Arthroplasty


Sponsor

Clinical Center of Vojvodina

Enrollment

90 participants

Start Date

May 25, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Surgical wound complications following primary total hip arthroplasty remain a significant clinical challenge despite advances in wound care technologies. The optimal choice of dressing and frequency of dressing changes remain insufficiently investigated, particularly regarding their influence on wound healing and the wound microenvironment. This prospective, randomized, controlled clinical trial aims to evaluate the impact of dressing type and dressing change frequency on surgical wound healing in patients undergoing primary total hip arthroplasty. Ninety patients will be allocated into three treatment groups receiving either a capillary-action dressing system (VACUTEX™) or standard dressings with different dressing change intervals. The study will assess time to complete wound epithelialization, postoperative wound complications, pain intensity, wound temperature, exudate pH, length of hospital stay, and time to suture removal. In addition, the study will investigate the potential role of wound temperature and exudate pH as early indicators of impaired healing and postoperative complications.


Eligibility

Min Age: 65 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Octenisept® wound care dressing and a medical device called VACUTEX™ wound dressing for people with total hip arthroplasty (tha) and wound healing time. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVACUTEX™ wound dressing

A capillary action-based wound management system designed for continuous removal of exudate without the use of external negative pressure, maintaining a moist wound environment and minimizing dressing adherence to the wound surface.

PROCEDUREOctenisept® wound care dressing

Standard postoperative wound care involving application of Octenisept® aqueous solution and sterile dressing for surgical wound management.


Locations(1)

Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina

Novi Sad, Serbia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07655388


Related Trials